BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chan Carusone S, Guta A, Robinson S, Tan DH, Cooper C, O'Leary B, de Prinse K, Cobb G, Upshur R, Strike C. "Maybe if I stop the drugs, then maybe they'd care?"-hospital care experiences of people who use drugs. Harm Reduct J 2019;16:16. [PMID: 30760261 DOI: 10.1186/s12954-019-0285-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gómez O, Sofuoglu M. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies. Drug Alcohol Depend 2021;228:109097. [PMID: 34601272 DOI: 10.1016/j.drugalcdep.2021.109097] [Reference Citation Analysis]
2 Nichols N, Malenfant J. Health System Access for Precariously Housed Youth: A Participatory Youth Research Project. Society and Mental Health. [DOI: 10.1177/21568693221082206] [Reference Citation Analysis]
3 Russell C, Ali F, Nafeh F, LeBlanc S, Imtiaz S, Elton-Marshall T, Rehm J. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada. BMC Public Health 2021;21:2021. [PMID: 34742267 DOI: 10.1186/s12889-021-12104-w] [Reference Citation Analysis]
4 Lewer D, Eastwood B, White M, Brothers TD, McCusker M, Copeland C, Farrell M, Petersen I. Fatal opioid overdoses during and shortly after hospital admissions in England: A case-crossover study. PLoS Med 2021;18:e1003759. [PMID: 34610017 DOI: 10.1371/journal.pmed.1003759] [Reference Citation Analysis]
5 Strike C, Robinson S, Guta A, Tan DH, O'Leary B, Cooper C, Upshur R, Chan Carusone S. Illicit drug use while admitted to hospital: Patient and health care provider perspectives. PLoS One 2020;15:e0229713. [PMID: 32134973 DOI: 10.1371/journal.pone.0229713] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Guta A, Perri M, Strike C, Gagnon M, Carusone SC. "With a PICC line, you never miss": The role of peripherally inserted central catheters in hospital care for people living with HIV/HCV who use drugs. Int J Drug Policy 2021;96:103438. [PMID: 34593288 DOI: 10.1016/j.drugpo.2021.103438] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Perry A, Lawrence V, Henderson C. Stigmatisation of those with mental health conditions in the acute general hospital setting. A qualitative framework synthesis. Soc Sci Med 2020;255:112974. [PMID: 32388323 DOI: 10.1016/j.socscimed.2020.112974] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
8 McPherson S, Gosrani S, Hogg S, Patel P, Wetten A, Welton R, Hallsworth K, Campbell M. Increased cardiovascular risk and reduced quality of life are highly prevalent among individuals with hepatitis C. BMJ Open Gastroenterol 2020;7:e000470. [PMID: 32847899 DOI: 10.1136/bmjgast-2020-000470] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chan CA, Canver B, McNeil R, Sue KL. Harm Reduction in Health Care Settings. Med Clin North Am 2022;106:201-17. [PMID: 34823731 DOI: 10.1016/j.mcna.2021.09.002] [Reference Citation Analysis]
10 Pearce LA, Homayra F, Dale LM, Moallef S, Barker B, Norton A, Hayashi K, Nosyk B. Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada. Int J Drug Policy 2020;84:102873. [PMID: 32731111 DOI: 10.1016/j.drugpo.2020.102873] [Reference Citation Analysis]
11 Kerman N, Manoni-millar S, Cormier L, Cahill T, Sylvestre J. “It’s not just injecting drugs”: Supervised consumption sites and the social determinants of health. Drug and Alcohol Dependence 2020;213:108078. [DOI: 10.1016/j.drugalcdep.2020.108078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
12 Ryan A, Garrod E, Fairbairn N. Caring for hospitalized patients during dual public health emergencies. J Subst Abuse Treat 2021;123:108271. [PMID: 33612200 DOI: 10.1016/j.jsat.2020.108271] [Reference Citation Analysis]
13 Lennox R, Lamarche L, O'Shea T. Peer support workers as a bridge: a qualitative study exploring the role of peer support workers in the care of people who use drugs during and after hospitalization. Harm Reduct J 2021;18:19. [PMID: 33593364 DOI: 10.1186/s12954-021-00467-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Figgatt MC, Salazar ZR, Vincent L, Carden-Glenn D, Link K, Kestner L, Yates T, Schranz A, Joniak-Grant E, Dasgupta N. Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina. Harm Reduct J 2021;18:80. [PMID: 34330297 DOI: 10.1186/s12954-021-00528-x] [Reference Citation Analysis]
15 Satinsky EN, Doran K, Felton JW, Kleinman M, Dean D, Magidson JF. Adapting a peer recovery coach-delivered behavioral activation intervention for problematic substance use in a medically underserved community in Baltimore City. PLoS One 2020;15:e0228084. [PMID: 32004328 DOI: 10.1371/journal.pone.0228084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Bhardwaj AM, Mhanna MJ, Abughali NF. Maternal risk factors associated with inadequate testing and loss to follow-up in infants with perinatal hepatitis C virus exposure. J Neonatal Perinatal Med 2021;14:123-9. [PMID: 32039866 DOI: 10.3233/NPM-190264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients' and hospital-based providers' perspectives. J Subst Abuse Treat 2021;:108708. [PMID: 34991950 DOI: 10.1016/j.jsat.2021.108708] [Reference Citation Analysis]
18 Saloner B, Lin L, Simon K. Geographic location of buprenorphine-waivered physicians and integration with health systems. J Subst Abuse Treat 2020;115:108034. [PMID: 32600622 DOI: 10.1016/j.jsat.2020.108034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Sumnall HR, Hamilton I, Atkinson AM, Montgomery C, Gage SH. Representation of adverse childhood experiences is associated with lower public stigma towards people who use drugs: an exploratory experimental study. Drugs: Education, Prevention and Policy 2021;28:227-39. [DOI: 10.1080/09687637.2020.1820450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Phillips C, Schulkind J, O'Sullivan M, Edelman N, Smith HE, Verma S, Jones CJ. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service. J Viral Hepat 2020;27:176-87. [PMID: 31566851 DOI: 10.1111/jvh.13214] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Curran JA, Somerville M, Boulos L, Caudarella A, Crowther D, Johnson C, Wozney L, MacPhee S, Sinclair D, Elliott Rose A, Jose C, Joudrey M. Identifying harm reduction strategies for alcohol and drug-use in inpatient care settings and emergency departments: a scoping review protocol. BMJ Open 2021;11:e055654. [PMID: 34711603 DOI: 10.1136/bmjopen-2021-055654] [Reference Citation Analysis]
22 Lennox R, Martin L, Brimner C, O'Shea T. Hospital policy as a harm reduction intervention for people who use drugs. Int J Drug Policy 2021;97:103324. [PMID: 34153628 DOI: 10.1016/j.drugpo.2021.103324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lennox R, Lamarche L, Martin L, O'Shea T, Belley-Côté E, Cvetkovic A, Virag O, Whitlock R. The Second Heart Program-A multidisciplinary team supporting people who inject drugs with infective endocarditis: Protocol of a feasibility study. PLoS One 2021;16:e0256839. [PMID: 34710094 DOI: 10.1371/journal.pone.0256839] [Reference Citation Analysis]
24 Muncan B, Walters SM, Ezell J, Ompad DC. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduct J 2020;17:53. [PMID: 32736624 DOI: 10.1186/s12954-020-00399-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]
25 Van Baelen L, Plettinckx E, Antoine J, De Ridder K, Devleesschauwer B, Gremeaux L. Use of health care services by people with substance use disorders in Belgium: a register-based cohort study. Arch Public Health 2021;79:112. [PMID: 34162427 DOI: 10.1186/s13690-021-00620-5] [Reference Citation Analysis]
26 Kitson C, Haines M, O’byrne P. Understanding the Perspectives of Women Who Use Intravenous Drugs and are Experiencing Homelessness in an Urban Centre in Canada: An Analysis of Ethnographic Data. Global Qualitative Nursing Research 2022;9:233339362210809. [DOI: 10.1177/23333936221080935] [Reference Citation Analysis]
27 Guta A, Buchman DZ, Schmidt RA, Perri M, Strike C. Trauma-Informed Approaches in Healthcare Ethics Consultation: A Missing Element in Healthcare for People Who Use Drugs during the Overdose Crisis? Am J Bioeth 2022;22:68-70. [PMID: 35475957 DOI: 10.1080/15265161.2022.2055208] [Reference Citation Analysis]
28 Haines M, O’byrne P. Nurse-led safer opioid supply and HIV pre-exposure prophylaxis: a novel pilot project. Therapeutic Advances in Infection 2022;9:204993612210914. [DOI: 10.1177/20499361221091418] [Reference Citation Analysis]